102 related articles for article (PubMed ID: 11073160)
1. Effect of EDTA on the resistance of clinical isolates of Acinetobacter baumannii to the bactericidal activity of normal human serum.
García A; Solar H; González C; Zemelman R
J Med Microbiol; 2000 Nov; 49(11):1047-1050. PubMed ID: 11073160
[TBL] [Abstract][Full Text] [Related]
2. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
Domenico P; Landolphi DR; Cunha BA
J Antimicrob Chemother; 1991 Dec; 28(6):801-10. PubMed ID: 1816178
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
[TBL] [Abstract][Full Text] [Related]
4. Some immunological properties of lipopolysaccharide from Acinetobacter baumannii.
GARCíA A; Salgado F; Solar H; GONZáLEZ CL; Zemelman R; OñTATE A
J Med Microbiol; 1999 May; 48(5):479-483. PubMed ID: 10229545
[TBL] [Abstract][Full Text] [Related]
5. [Antimicrobial resistance of different Acinetobacter baumannii biotypes isolated in the northern region of Chile].
Silva J; Avello C; Matamoro F; Villagra L; Rojas V; Sandoval L
Rev Med Chil; 1999 Aug; 127(8):926-34. PubMed ID: 10752253
[TBL] [Abstract][Full Text] [Related]
6. Bismuth-dimercaprol exposes surface components of Klebsiella pneumoniae camouflaged by the polysaccharide capsule.
Domenico P; Tomas JM; Merino S; Rubires X; Cunha BA
Ann N Y Acad Sci; 1996 Oct; 797():269-70. PubMed ID: 8993376
[No Abstract] [Full Text] [Related]
7. Effects of permeabilizers on antimicrobial susceptibility of Stenotrophomonas maltophilia and Acinetobacter spp.
Denny B; West P; Panigrahi D
J Microbiol Immunol Infect; 2003 Mar; 36(1):72-6. PubMed ID: 12741739
[TBL] [Abstract][Full Text] [Related]
8. Adherence of Acinetobacter baumannii to rat bladder tissue.
Sepulveda M; Ruiz M; Bello H; Dominguez M; Martínez MA; Pinto ME; Gonzalez G; Mella S; Zemelman R
Microbios; 1998; 95(380):45-53. PubMed ID: 9881463
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
[TBL] [Abstract][Full Text] [Related]
10. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii.
King LB; Swiatlo E; Swiatlo A; McDaniel LS
FEMS Immunol Med Microbiol; 2009 Apr; 55(3):414-21. PubMed ID: 19220466
[TBL] [Abstract][Full Text] [Related]
11. Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro.
Vila-Farrés X; Ferrer-Navarro M; Callarisa AE; Martí S; Espinal P; Gupta S; Rolain JM; Giralt E; Vila J
J Antimicrob Chemother; 2015 Nov; 70(11):2981-6. PubMed ID: 26311838
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
13. Clinical Isolates of
Magda M; Bettoni S; Laabei M; Fairley D; Russo TA; Riesbeck K; Blom AM
Front Immunol; 2022; 13():814193. PubMed ID: 35173727
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of bismuth subsalicylate.
Cornick NA; Silva M; Gorbach SL
Rev Infect Dis; 1990; 12 Suppl 1():S9-10. PubMed ID: 2305178
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of serum resistance for Pseudomonas aeruginosa and Acinetobacter baumannii strains].
Cevahir N; Kaleli I; Demir M; Yildirim U; Cevik E; Gürbüz M
Mikrobiyol Bul; 2006 Jul; 40(3):251-5. PubMed ID: 17001855
[TBL] [Abstract][Full Text] [Related]
16. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility.
McQueary CN; Kirkup BC; Si Y; Barlow M; Actis LA; Craft DW; Zurawski DV
J Microbiol; 2012 Jun; 50(3):434-43. PubMed ID: 22752907
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
[TBL] [Abstract][Full Text] [Related]
18. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
[TBL] [Abstract][Full Text] [Related]
19. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.
Castanheira M; Mendes RE; Jones RN
Clin Infect Dis; 2014 Dec; 59 Suppl 6():S367-73. PubMed ID: 25371512
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
